Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

P3 Health Partners (PIII) Depreciation and Depletion (2021 - 2025)

P3 Health Partners (PIII) has disclosed Depreciation and Depletion for 5 consecutive years, with $500000.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Depreciation and Depletion changed N/A year-over-year to $500000.0, compared with a TTM value of $2.4 million through Sep 2025, changed N/A, and an annual FY2024 reading of $2.4 million, up 4.35% over the prior year.
  • Depreciation and Depletion was $500000.0 for Q3 2025 at P3 Health Partners, down from $600000.0 in the prior quarter.
  • Across five years, Depreciation and Depletion topped out at $700000.0 in Q4 2024 and bottomed at $332548.0 in Q1 2021.
  • Average Depreciation and Depletion over 5 years is $566610.6, with a median of $600000.0 recorded in 2022.
  • The sharpest move saw Depreciation and Depletion soared 80.43% in 2022, then dropped 16.67% in 2023.
  • Year by year, Depreciation and Depletion stood at $332548.0 in 2021, then skyrocketed by 80.43% to $600000.0 in 2022, then decreased by 16.67% to $500000.0 in 2023, then soared by 40.0% to $700000.0 in 2024, then fell by 28.57% to $500000.0 in 2025.
  • Business Quant data shows Depreciation and Depletion for PIII at $500000.0 in Q3 2025, $600000.0 in Q2 2025, and $600000.0 in Q1 2025.